A detailed history of Well Done, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Well Done, LLC holds 2,075 shares of MRK stock, worth $211,401. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,075
Previous 1,948 6.52%
Holding current value
$211,401
Previous $241,000 2.49%
% of portfolio
0.04%
Previous 0.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$111.15 - $128.97 $14,116 - $16,379
127 Added 6.52%
2,075 $235,000
Q2 2024

Jul 18, 2024

BUY
$123.8 - $132.96 $2,599 - $2,792
21 Added 1.09%
1,948 $241,000
Q1 2024

Apr 18, 2024

SELL
$113.24 - $131.95 $7,700 - $8,972
-68 Reduced 3.41%
1,927 $254,000
Q4 2023

Jan 18, 2024

BUY
$100.18 - $109.02 $4,908 - $5,341
49 Added 2.52%
1,995 $217,000
Q3 2023

Oct 16, 2023

BUY
$102.95 - $114.33 $20,281 - $22,523
197 Added 11.26%
1,946 $200,000
Q2 2023

Jul 20, 2023

SELL
$108.61 - $118.38 $57,020 - $62,149
-525 Reduced 23.09%
1,749 $201,000
Q1 2023

Apr 20, 2023

SELL
$102.94 - $114.86 $3,499 - $3,905
-34 Reduced 1.47%
2,274 $241,000
Q4 2022

Jan 17, 2023

BUY
$87.44 - $112.11 $201,811 - $258,749
2,308 New
2,308 $0
Q2 2022

Jul 18, 2022

BUY
$83.49 - $94.64 $250 - $283
3 Added 0.12%
2,502 $228,000
Q1 2022

Apr 20, 2022

SELL
$73.51 - $82.4 $55,720 - $62,459
-758 Reduced 23.27%
2,499 $205,000
Q4 2021

Jan 21, 2022

BUY
$72.28 - $90.54 $795 - $995
11 Added 0.34%
3,257 $250,000
Q3 2021

Nov 01, 2021

SELL
$71.68 - $78.83 $18,780 - $20,653
-262 Reduced 7.47%
3,246 $244,000
Q2 2021

Jul 19, 2021

BUY
$70.31 - $77.77 $9,421 - $10,421
134 Added 3.97%
3,508 $273,000
Q1 2021

Apr 29, 2021

BUY
$68.86 - $81.11 $44,965 - $52,964
653 Added 24.0%
3,374 $260,000
Q4 2020

Feb 02, 2021

BUY
$71.77 - $79.65 $13,564 - $15,053
189 Added 7.46%
2,721 $222,000
Q3 2020

Oct 19, 2020

BUY
$73.18 - $82.95 $185,291 - $210,029
2,532 New
2,532 $210,000
Q1 2020

Apr 16, 2020

SELL
$63.36 - $87.82 $160,047 - $221,833
-2,526 Closed
0 $0
Q4 2019

Jan 29, 2020

SELL
$77.58 - $87.54 $31,419 - $35,453
-405 Reduced 13.82%
2,526 $230,000
Q3 2019

Oct 15, 2019

BUY
$76.08 - $82.93 $76 - $82
1 Added 0.03%
2,931 $247,000
Q2 2019

Jul 19, 2019

BUY
$69.84 - $81.59 $139 - $163
2 Added 0.07%
2,930 $246,000
Q1 2019

May 09, 2019

BUY
$69.58 - $79.36 $11,480 - $13,094
165 Added 5.97%
2,928 $244,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $180,258 - $209,186
2,763 New
2,763 $211,000
Q2 2018

Aug 03, 2018

SELL
$50.83 - $59.72 $107,708 - $126,546
-2,119 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $107,984 - $125,508
2,119 New
2,119 $115,000
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $241,065 - $287,858
-4,670 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$58.67 - $63.13 $273,988 - $294,817
4,670
4,670 $299,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Well Done, LLC Portfolio

Follow Well Done, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Well Done, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Well Done, LLC with notifications on news.